These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 24875486

  • 1. Early ischemic blood brain barrier damage: a potential indicator for hemorrhagic transformation following tissue plasminogen activator (tPA) thrombolysis?
    Jin X, Liu J, Liu W.
    Curr Neurovasc Res; 2014; 11(3):254-62. PubMed ID: 24875486
    [Abstract] [Full Text] [Related]

  • 2. Normobaric hyperoxia slows blood-brain barrier damage and expands the therapeutic time window for tissue-type plasminogen activator treatment in cerebral ischemia.
    Liang J, Qi Z, Liu W, Wang P, Shi W, Dong W, Ji X, Luo Y, Liu KJ.
    Stroke; 2015 May; 46(5):1344-1351. PubMed ID: 25804925
    [Abstract] [Full Text] [Related]

  • 3. Oxygen or cooling, to make a decision after acute ischemia stroke.
    Liu WC, Jin XC.
    Med Gas Res; 2016 May; 6(4):206-211. PubMed ID: 28217292
    [Abstract] [Full Text] [Related]

  • 4. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.
    Zhang Y, Wang Y, Zuo Z, Wang Z, Roy J, Hou Q, Tong E, Hoffmann A, Sperberg E, Bredno J, Berr SS, Xie M, Lee K, Wintermark M.
    J Neurol Sci; 2014 Dec 15; 347(1-2):148-54. PubMed ID: 25292413
    [Abstract] [Full Text] [Related]

  • 5. Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator.
    Shimada Y, Shimura H, Tanaka R, Yamashiro K, Koike M, Uchiyama Y, Urabe T, Hattori N.
    PLoS One; 2018 Dec 15; 13(5):e0198039. PubMed ID: 29795667
    [Abstract] [Full Text] [Related]

  • 6. Rosiglitazone ameliorates tissue plasminogen activator-induced brain hemorrhage after stroke.
    Li Y, Zhu ZY, Lu BW, Huang TT, Zhang YM, Zhou NY, Xuan W, Chen ZA, Wen DX, Yu WF, Li PY.
    CNS Neurosci Ther; 2019 Dec 15; 25(12):1343-1352. PubMed ID: 31756041
    [Abstract] [Full Text] [Related]

  • 7. Cell permeable HMGB1-binding heptamer peptide ameliorates neurovascular complications associated with thrombolytic therapy in rats with transient ischemic stroke.
    Li M, Chen S, Shi X, Lyu C, Zhang Y, Tan M, Wang C, Zang N, Liu X, Hu Y, Shen J, Zhou L, Gu Y.
    J Neuroinflammation; 2018 Aug 23; 15(1):237. PubMed ID: 30139371
    [Abstract] [Full Text] [Related]

  • 8. Transient brain hypothermia reduces the reperfusion injury of delayed tissue plasminogen activator and extends its therapeutic time window in a focal embolic stroke model.
    Zarisfi M, Allahtavakoli F, Hassanipour M, Khaksari M, Rezazadeh H, Allahtavakoli M, Taghavi MM.
    Brain Res Bull; 2017 Sep 23; 134():85-90. PubMed ID: 28710023
    [Abstract] [Full Text] [Related]

  • 9. 17β-estradiol attenuates breakdown of blood-brain barrier and hemorrhagic transformation induced by tissue plasminogen activator in cerebral ischemia.
    Li M, Zhang Z, Sun W, Koehler RC, Huang J.
    Neurobiol Dis; 2011 Dec 23; 44(3):277-83. PubMed ID: 21816222
    [Abstract] [Full Text] [Related]

  • 10. Matrix metalloproteinase activation and blood-brain barrier breakdown following thrombolysis.
    Kelly MA, Shuaib A, Todd KG.
    Exp Neurol; 2006 Jul 23; 200(1):38-49. PubMed ID: 16624294
    [Abstract] [Full Text] [Related]

  • 11. Mesenchymal stem cell-derived extracellular vesicles attenuate tPA-induced blood-brain barrier disruption in murine ischemic stroke models.
    Qiu L, Cai Y, Geng Y, Yao X, Wang L, Cao H, Zhang X, Wu Q, Kong D, Ding D, Shi Y, Wang Y, Wu J.
    Acta Biomater; 2022 Dec 23; 154():424-442. PubMed ID: 36367475
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of Chinese herbal medicine for tPA thrombolysis in experimental stroke: A systematic review and meta-analysis.
    Ye Y, Zhu YT, Xin XY, Zhang JC, Zhang HL, Li D.
    Phytomedicine; 2022 Jun 23; 100():154072. PubMed ID: 35349833
    [Abstract] [Full Text] [Related]

  • 13. Melatonin attenuates the postischemic increase in blood-brain barrier permeability and decreases hemorrhagic transformation of tissue-plasminogen activator therapy following ischemic stroke in mice.
    Chen TY, Lee MY, Chen HY, Kuo YL, Lin SC, Wu TS, Lee EJ.
    J Pineal Res; 2006 Apr 23; 40(3):242-50. PubMed ID: 16499561
    [Abstract] [Full Text] [Related]

  • 14. α7nACh receptor, a promising target to reduce BBB damage by regulating inflammation and autophagy after ischemic stroke.
    Gao F, Du W, Guo C, Geng P, Liu W, Jin X.
    Biomed Pharmacother; 2024 Oct 23; 179():117337. PubMed ID: 39191022
    [Abstract] [Full Text] [Related]

  • 15. Canonical Wnt Pathway Maintains Blood-Brain Barrier Integrity upon Ischemic Stroke and Its Activation Ameliorates Tissue Plasminogen Activator Therapy.
    Jean LeBlanc N, Menet R, Picard K, Parent G, Tremblay MÈ, ElAli A.
    Mol Neurobiol; 2019 Sep 23; 56(9):6521-6538. PubMed ID: 30852795
    [Abstract] [Full Text] [Related]

  • 16. Recombinant ADAMTS13 reduces tissue plasminogen activator-induced hemorrhage after stroke in mice.
    Wang L, Fan W, Cai P, Fan M, Zhu X, Dai Y, Sun C, Cheng Y, Zheng P, Zhao BQ.
    Ann Neurol; 2013 Feb 23; 73(2):189-98. PubMed ID: 23280993
    [Abstract] [Full Text] [Related]

  • 17. Hemorrhagic Transformation after Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke: Mechanisms, Models, and Biomarkers.
    Wang W, Li M, Chen Q, Wang J.
    Mol Neurobiol; 2015 Dec 23; 52(3):1572-1579. PubMed ID: 25367883
    [Abstract] [Full Text] [Related]

  • 18. Effects of tissue plasminogen activator on cerebral microvessels of rats during focal cerebral ischemia and reperfusion.
    Yang DY, Pan HC, Chen CJ, Cheng FC, Wang YC.
    Neurol Res; 2007 Apr 23; 29(3):274-82. PubMed ID: 17509227
    [Abstract] [Full Text] [Related]

  • 19. Increased Plasma Matrix Metalloproteinase-9 Levels Contribute to Intracerebral Hemorrhage during Thrombolysis after Concomitant Stroke and Influenza Infection.
    Muhammad S, Planz O, Schwaninger M.
    Cerebrovasc Dis Extra; 2016 Apr 23; 6(2):50-9. PubMed ID: 27560521
    [Abstract] [Full Text] [Related]

  • 20. High-density lipoprotein-based therapy reduces the hemorrhagic complications associated with tissue plasminogen activator treatment in experimental stroke.
    Lapergue B, Dang BQ, Desilles JP, Ortiz-Munoz G, Delbosc S, Loyau S, Louedec L, Couraud PO, Mazighi M, Michel JB, Meilhac O, Amarenco P.
    Stroke; 2013 Mar 23; 44(3):699-707. PubMed ID: 23422087
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.